The SLL-produced series “Doctor Cha” is set to be remade in Turkish, which has been a huge hit, recording meaningful figures in both Korean and global viewership indicators.
SLL announced on Wednesday that it has signed a deal with Turkish production company MF Yapim to remake “Doctor Cha.” MF Yapim was founded in 2012 as a partnership between Faruk Bayhan, who has over 40 years of experience in the Turkish media industry, and MEDYAPIM, a leading production company in Turkey. Since then MF Yapim has successfully produced many drama series including many format adaptations from South Korea, Japan, United Kingdom and other countries.
“Doctor Cha” follows the story of a middle-aged housewife who decides to get back to her medical career after surviving an unexpected crisis. She starts her first year of medical residency at the hospital where her disapproving husband works, unaware of the fact that her husband is having a secret affair with another doctor. The combination of the story and SLL’s production capabilities led the show to rank in Netflix’s Global Top 10 lists of Non-English TV categories for seven weeks, with the best ranking of Number 2. In Korea, the series became a phenomenon, with a peak viewership rating of 18.5% (Nielsen Korea, based on paid subscriptions).
As the original series conveyed empathy and comfort to the viewers and shared stories about true happiness, the Turkish version of “Doctor Cha” is expected to make a deep impression on the Turkish audience, as well.
Charles Park, SVP of Content Business at SLL, said: “We are excited to see a Turkish version of one of our most successful series this year and hope to extend this opportunity to see more international adaptations of our formats.”
Asena Bulbuloglu, General Manager of MF Yapim, said: “Since its establishment, our company has successfully adapted many Korean formats in Turkey and exported them to many countries. We hope to achieve the same success with “Doctor Cha,” our first agreement with SLL, and wish it is to be the first of many to follow.”